TORONTO, Feb. 10, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP, FTRP.WT, OTCQX: FTRPF) (“Field Trip”), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its third fiscal quarter ended December 31, 2020, after market close on Tuesday, February 16, 2021. The Company will conduct a conference call and…

Source

Previous articleSilo Pharma Announces Private Placement of Equity Definitive Agreement for $4.275 Million in Gross Proceeds
Next articlePsyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider to Conduct Observational Study